Higher expression levels of MBOAT2, CDA, LPCAT2 and B4GALT5 were observed to be notably linked with poorer overall survival rates in PACA patients (Figure 4). Here, MBOAT2 is linked to permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.